Exelixis, Inc.
🏢 View company profile →173Patents
137Active
173Granted
55Portfolio score
Filing activity: May 26, 1998 → Nov 25, 2024 · 70 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7265131B2 | Isoquinolinone derivatives and their use as therapeutic agents | Chemistry; Metallurgy | 136 | Expired |
| US7579473B2 | c-Met modulators and methods of use | Emerging Cross-Sectional Technologies | 63 | Active |
| US6703491B1 | Drosophila sequences | Human Necessities | 61 | Expired |
| US7704995B2 | Protein kinase modulators and methods of use | Chemistry; Metallurgy | 60 | Expired |
| US8497284B2 | C-met modulators and method of use | Emerging Cross-Sectional Technologies | 50 | Active |
| US8877776B2 | (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | Chemistry; Metallurgy | 47 | Active |
| US7999006B2 | Methods of using MEK inhibitors | Human Necessities | 45 | Active |
| US8067436B2 | c-Met modulators and methods of use | Emerging Cross-Sectional Technologies | 44 | Active |
| US7989622B2 | Phosphatidylinositol 3-kinase inhibitors and methods of their use | Emerging Cross-Sectional Technologies | 43 | Active |
| US8178532B2 | c-Met modulators and method of use | Emerging Cross-Sectional Technologies | 40 | Active |
| US7977345B2 | c-MET modulators and method of use | Chemistry; Metallurgy | 39 | Active |
| US8476298B2 | c-Met modulators and method of use | Emerging Cross-Sectional Technologies | 37 | Active |
| US9724342B2 | C-met modulator pharmaceutical compositions | Human Necessities | 35 | Active |
| US8673912B2 | Crystalline Forms on N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | Human Necessities | 33 | Active |
| US7485634B2 | Azepinoindole and pyridoindole derivatives as pharmaceutical agents | Chemistry; Metallurgy | 29 | Expired |
| US8222256B2 | Methods of using IGFIR and ABL kinase modulators | Human Necessities | 28 | Active |
| US7803839B2 | Azetidines as MEK inhibitors for the treatment of proliferative diseases | Chemistry; Metallurgy | 28 | Active |
| US10034873B2 | C-met modulator pharmaceutical compositions | Human Necessities | 27 | Active |
| US9717720B2 | Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds | Chemistry; Metallurgy | 26 | Active |
| US10039757B2 | C-Met modulator pharmaceutical compositions | Human Necessities | 26 | Active |
| US9809549B2 | Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer | Chemistry; Metallurgy | 24 | Active |
| US6511824B1 | Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use | Human Necessities | 21 | Expired |
| US9365516B2 | Process for preparing quinoline derivatives | Chemistry; Metallurgy | 21 | Active |
| US6852290B2 | Multi-well apparatus | Emerging Cross-Sectional Technologies | 21 | Expired |
| US8642584B2 | Method of using PI3K and MEK modulators | Chemistry; Metallurgy | 20 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.